← Back to Clinical Trials
Recruiting NCT04426448

NCT04426448 Assessment of a Brief Post Traumatic Stress Disorder Intervention for Use in Botswana

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04426448
Status Recruiting
Phase
Sponsor University of Botswana
Condition Post Traumatic Stress Disorder
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2020-07-08
Primary Completion 2025-08-30

Trial Parameters

Condition Post Traumatic Stress Disorder
Sponsor University of Botswana
Study Type INTERVENTIONAL
Phase N/A
Enrollment 36
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2020-07-08
Completion 2025-08-30
Interventions
Brief Relaxation, Education And Trauma HEaling

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to culturally adapt a brief psychological intervention for Post-Traumatic Stress Disorder (PTSD) and assess its efficacy, feasibility, and acceptability in a pilot trial. The intervention has been shown to be efficacious among individuals with comorbid severe mental illness (SMI) and PTSD. The study will be conducted in three phases. The first phase will determine a description of trauma and responses to traumatic experiences among patients with severe mental illness. The first phase of the study will also determine participants' and mental health care providers' perceptions of suitable PTSD interventions in this middle-income context. The findings will then be used to culturally adapt the brief intervention in the second phase. A pilot trial will be conducted in the third phase of the study. Participants with comorbid SMI and PTSD will be randomized into two groups (n= 20 intervention group, n= 20 control group). Outcomes of the intervention such as the severity of PTSD symptoms, knowledge about PTSD will be assessed at baseline and at different timelines during the study. This study will fill the knowledge gap on trauma and its consequences among individuals with severe mental illness in Botswana, it will also contribute to the improvement of clinical practice in the management of PTSD and SMI.

Eligibility Criteria

Inclusion Criteria: * Able to understand Setswana or English * The patient must meet the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) criteria for any SMI as categorized for this study (schizophrenia, schizophreniform disorder, schizoaffective disorder, bipolar mood disorder, and severe depressive disorder) * The patient should meet the criteria for Post-Traumatic Stress Disorder as assessed with the Post Traumatic Checklist-5 (PCL-5) Exclusion Criteria: * Currently engaged in psychotherapy for PTSD * On pharmacotherapy management of PTSD (to control for medication effects on PTSD symptoms) * Inability to understand informed consent * Inability to respond to interview questions * Patients who have suicidal ideation and history of a suicide attempt within the past 6 months

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology